|
|
|
| Webinar: Mastering the Complexities of Gene Therapy Document Writing | Gene therapy is complex—and so is writing about it. From viral vectors to cell types, every element demands deep understanding. Safety reporting adds further complexity: is an adverse event from chemotherapy, a procedure, or the gene therapy itself? These challenges require a thoughtful, flexible approach to document strategy and execution. Explore common hurdles and practical solutions for gene therapy document writing and submissions. |
|
|
|
|
By Raymond Forslund, Ph.D., MBA, Syner-G Biopharma Group | Syner-G Biopharma Group's Raymond Forslund, Ph.D., MBA explores how U.S. tariffs might affect biotech manufacturing, funding, and clinical research. | |
|
|
|
|
| RTSM/IRT In Clinical Trials: The Complete Guide | Article | Signant Health | RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance. |
|
|
| Risk Mitigation Planning For Pharmaceutical Tariffs | Article | By Steve Kornher, Ph.D., Halloran Consulting | Examine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability. |
|
|
| Artificial Intelligence Regulation | e-book | Citeline | To make the best use of artificial intelligence (AI), drug sponsors need to understand where health authorities are drawing the lines. |
|
|
.png){kind=logo}
